Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamil Bashir

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
American Heart Journal|November 7, 2018
Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate SubjectsBlandine Mondésert, Jamil Bashir, François Philippon, et al.
Journal of the American College of Cardiology|February 16, 2010
Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractionsOussama Wazni, Laurence M Epstein, Roger G Carrillo, et al.
Circulation|May 26, 2010
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory CommitteeRatika Parkash, Eugene Crystal, Jamil Bashir, et al.
JACC. Clinical Electrophysiology|July 13, 2024
Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized TrialDarryl P Leong, Hisham Dokainish, Blandine Mondésert, et al.
Annals of Internal Medicine|November 7, 2022
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter TrialJeff S Healey, Andrew D Krahn, Jamil Bashir, et al.
Open Forum Infectious Diseases|December 3, 2021
Impact of Choice of Prophylaxis on the Microbiology of Cardiac Implantable Electronic Device Infections: Insights From the Prevention of Arrhythmia Device Infection Trial (PADIT)Yves Longtin, Philippe Gervais, David H Birnie, et al.
Journal of the American College of Cardiology|December 7, 2019
Risk Factors for Infections Involving Cardiac Implanted Electronic DevicesDavid H Birnie, Jia Wang, Marco Alings, et al.
Journal of the American College of Cardiology|December 15, 2018
Prevention of Arrhythmia Device Infection Trial: The PADIT TrialAndrew D Krahn, Yves Longtin, François Philippon, et al.
JAMA Cardiology|April 5, 2023
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With MortalityHui-Chen Han, Jia Wang, David H Birnie, et al.
The Canadian Journal of Cardiology|January 15, 2026
The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic DevicesJason G Andrade, Jacqueline Joza, Derek S Chew, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
American Heart Journal|November 7, 2018
Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate SubjectsBlandine Mondésert, Jamil Bashir, François Philippon, et al.
Journal of the American College of Cardiology|February 16, 2010
Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractionsOussama Wazni, Laurence M Epstein, Roger G Carrillo, et al.
Circulation|May 26, 2010
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory CommitteeRatika Parkash, Eugene Crystal, Jamil Bashir, et al.
JACC. Clinical Electrophysiology|July 13, 2024
Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized TrialDarryl P Leong, Hisham Dokainish, Blandine Mondésert, et al.
Annals of Internal Medicine|November 7, 2022
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter TrialJeff S Healey, Andrew D Krahn, Jamil Bashir, et al.
Open Forum Infectious Diseases|December 3, 2021
Impact of Choice of Prophylaxis on the Microbiology of Cardiac Implantable Electronic Device Infections: Insights From the Prevention of Arrhythmia Device Infection Trial (PADIT)Yves Longtin, Philippe Gervais, David H Birnie, et al.
Journal of the American College of Cardiology|December 7, 2019
Risk Factors for Infections Involving Cardiac Implanted Electronic DevicesDavid H Birnie, Jia Wang, Marco Alings, et al.
Journal of the American College of Cardiology|December 15, 2018
Prevention of Arrhythmia Device Infection Trial: The PADIT TrialAndrew D Krahn, Yves Longtin, François Philippon, et al.
JAMA Cardiology|April 5, 2023
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With MortalityHui-Chen Han, Jia Wang, David H Birnie, et al.
The Canadian Journal of Cardiology|January 15, 2026
The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic DevicesJason G Andrade, Jacqueline Joza, Derek S Chew, et al.
Pageof 6